81
Participants
Start Date
November 25, 2021
Primary Completion Date
April 30, 2024
Study Completion Date
May 7, 2024
Nintedanib
Soft gelatin capsule
Placebo
Soft gelatin capsule
Tianjin Medical University General Hospital, Tianjin
China-Japan Friendship Hospital, Beijing
The Second Hospital of Jilin University, Changchun
Shanghai Chest Hospital, Shanghai
Huashan Hospital, Fudan University, Shanghai
Shanghai Pulmonary Hospital, Shanghai
Nanjing Drum Tower Hospital, Nanjing
Hangzhou First People's Hospital, Hangzhou
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Zhejiang Hospital, Hangzhou
The First Affiliated Hospital of Wenzhou Med College, Wenzhou
Xiangya Hospital, Central South University, Changsha
Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T, Wuhan
First Affiliated Hospital of Guangzhou Medical University, Guangzhou
West China Hospital, Chengdu
General Hospital of Ningxia Medical University, Yinchuan
Lead Sponsor
Boehringer Ingelheim
INDUSTRY